Indexed in Journament

European journal of cancer (Oxford, England : 1990)

ISSN 1879-0852· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
40.3 / 100
Journament Score
Below Average
Ranked #9,262 of 33,995 indexed journals
24 Articles
Accessibility 35
Engagement 31
The Journament Score combines content quality, publication ethics and transparency, editorial standards, publication regularity, accessibility and reader engagement into a single 0–100 figure. It is recalculated as new articles and metadata are indexed.

About This Journal

Short Name Eur J Cancer
Abbreviated Name eur j cancer
ISSN 1879-0852
URL https://www.journals.elsevier.com/european-journal-of-cancer

Publications Per Year

Articles (24)

1996
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin
Dompeling EC;Donnelly JP;Deresinski SC;Feld R;Lane-Allman EF;De Pauw BE;;
Vol. 32A , No. 8 , pp. -
474 views Abstract
2001
Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution
Haupt R;Romanengo M;Fears T;Viscoli C;Castagnola E;;
Vol. 37 , No. 18 , pp. -
440 views Abstract
2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting.
Corbaux, Pauline;Maillet, Denis;Boespflug, Amélie;Locatelli-Sanchez, Myriam;Perier-Muzet, Marie;Duruisseaux, Michaël;Kiakouama-Maleka, Lize;Dalle, Stéphane;Falandry, Claire;Péron, Julien;
Vol. 121 , pp. 192-201
419 views DOI Abstract
2019
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.
Davidson, Michael;Aronson, Lauren I;Howard-Reeves, Julie;Bryant, Hanna;Cutts, Rosalind J;Hulkki-Wilson, Sanna;Kouvelakis, Kyriakos;Kalaitzaki, Eftheleria;Watkins, David;Starling, Naureen;Rao, Sheela;Cardenosa, Marta Llorca;Begum, Ruwaida;Rana, Isma;Lazaro-Alcausi, Retchel;Terlizzo, Monica;Wotherspoon, Andrew;Brown, Gina;Swansbury, John;Lord, Christopher J;Cunningham, David;Chau, Ian;Chong, Irene Y;
Vol. 122 , pp. 12-21
415 views DOI Abstract
2019
Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.
Hohenberger, Peter;Bonvalot, Sylvie;van Coevorden, Frits;Rutkowski, Pjotr;Stoeckle, Eberhard;Olungu, Christine;Litiere, Saskia;Wardelmann, Eva;Gronchi, Alessandro;Casali, Paolo;
Vol. 120 , pp. 47-53
408 views DOI Abstract
2020
Comment on "The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region" and reflections from the Italian Association of Oncology Nurses.
Biagioli, Valentina;Belloni, Silvia;Albanesi, Beatrice;Piredda, Alessio;Caruso, Rosario;
Vol. 135 , pp. 8-10
392 views DOI
2019
Superior skin cancer classification by the combination of human and artificial intelligence.
Hekler, Achim;Utikal, Jochen S;Enk, Alexander H;Hauschild, Axel;Weichenthal, Michael;Maron, Roman C;Berking, Carola;Haferkamp, Sebastian;Klode, Joachim;Schadendorf, Dirk;Schilling, Bastian;Holland-Letz, Tim;Izar, Benjamin;von Kalle, Christof;Fröhling, Stefan;Brinker, Titus J;, ;
Vol. 120 , pp. 114-121
386 views DOI Abstract
1993
Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours.
Olweny, C L;Juttner, C A;Rofe, P;Barrow, G;Esterman, A;Waltham, R;Abdi, E;Chesterman, H;Seshadri, R;Sage, E;
Vol. 29A , No. 6 , pp. 826-30
363 views Abstract
2020
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).
Cafferty, Fay H;White, Jeff D;Shamash, Jonathan;Hennig, Ivo;Stenning, Sally P;Huddart, Robert A;, ;
Vol. 127 , pp. 139-149
362 views DOI Abstract
2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
Yang, Qi;Cao, Su-Mei;Guo, Ling;Hua, Yi-Jun;Huang, Pei-Yu;Zhang, Xiao-Long;Lin, Mei;You, Rui;Zou, Xiong;Liu, You-Ping;Xie, Yu-Long;Wang, Zhi-Qiang;Mai, Hai-Qiang;Chen, Qiu-Yan;Tang, Lin-Quan;Mo, Hao-Yuan;Cao, Ka-Jia;Qian, Chao-Nan;Zhao, Chong;Xiang, Yan-Qun;Zhang, Xiu-Ping;Lin, Zhi-Xiong;Li, Wei-Xiong;Liu, Qing;Li, Ji-Bin;Ling, Li;Guo, Xiang;Hong, Ming-Huang;Chen, Ming-Yuan;
Vol. 119 , pp. 87-96
356 views DOI Abstract
2025
Advances and challenges in targeted therapies for HER2-amplified colorectal cancer.
Pizzamiglio, Margot; Soulabaille, Audrey; Lahlou, Widad; Pilla, Lorenzo; Zaanan, Aziz; Taieb, Julien
Vol. 222 , pp. 115471
73 views DOI Abstract
2021
Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer - an Australian multi-centre observational study.
Anton, Angelyn;Wong, Shirley;Shapiro, Julia;Weickhardt, Andrew;Azad, Arun;Kwan, Edmond M;Spain, Lavinia;Gunjur, Ashray;Torres, Javier;Parente, Phillip;Parnis, Francis;Goh, Jeffrey;Semira, Marie C;Gibbs, Peter;Tran, Ben;Pezaro, Carmel;
Vol. 157 , pp. 485-492
103 views DOI Abstract
2020
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial
Cibula D;Kocian R;Plaikner A;Jarkovsky J;Klat J;Zapardiel I;Pilka R;Torne A;Sehnal B;Ostojich M;Petiz A;Sanchez OA;Presl J;Buda A;Raspagliesi F;Kascak P;van Lonkhuijzen L;Barahona M;Minar L;Blecharz P;Pakiz M;Wydra D;Snyman LC;Zalewski K;Zorrero C;Havelka P;Redecha M;Vinnytska A;Vergote I;Tingulstad S;Michal M;Kipp B;Slama J;Marnitz S;Bajsova S;Hernandez A;Fischerova D;Nemejcova K;Kohler C;;
Vol. 137 , pp. -
242 views Abstract
2020
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment
Hrusak O;Kalina T;Wolf J;Balduzzi A;Provenzi M;Rizzari C;Rives S;Del Pozo Carlavilla M;Alonso MEV;Domínguez-Pinilla N;Bourquin JP;Schmiegelow K;Attarbaschi A;Grillner P;Mellgren K;van der Werff Ten Bosch J;Pieters R;Brozou T;Borkhardt A;Escherich G;Lauten M;Stanulla M;Smith O;Yeoh AEJ;Elitzur S;Vora A;Li CK;Ariffin H;Kolenova A;Dallapozza L;Farah R;Lazic J;Manabe A;Styczynski J;Kovacs G;Ottoffy G;Felice MS;Buldini B;Conter V;Stary J;Schrappe M;;
Vol. 132 , pp. -
297 views Abstract
2020
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.
Souza, Ive L;Fernandes, Ítalo;Taranto, Patrícia;Buzaid, Antonio C;Schvartsman, Gustavo;
Vol. 135 , pp. 147-149
307 views DOI
2020
Comment on "The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region" and reflections from the Italian Association of Oncology Nurses.
Biagioli, Valentina;Belloni, Silvia;Albanesi, Beatrice;Piredda, Alessio;Caruso, Rosario;
Vol. 135 , pp. 8-10
392 views DOI
2020
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).
Cafferty, Fay H;White, Jeff D;Shamash, Jonathan;Hennig, Ivo;Stenning, Sally P;Huddart, Robert A;, ;
Vol. 127 , pp. 139-149
362 views DOI Abstract
2019
Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
Summers, Matthew G;Maughan, Timothy S;Kaplan, Richard;Law, Philip J;Houlston, Richard S;Escott-Price, Valentina;Cheadle, Jeremy P;
Vol. 124 , pp. 56-63
264 views DOI Abstract
2019
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.
Davidson, Michael;Aronson, Lauren I;Howard-Reeves, Julie;Bryant, Hanna;Cutts, Rosalind J;Hulkki-Wilson, Sanna;Kouvelakis, Kyriakos;Kalaitzaki, Eftheleria;Watkins, David;Starling, Naureen;Rao, Sheela;Cardenosa, Marta Llorca;Begum, Ruwaida;Rana, Isma;Lazaro-Alcausi, Retchel;Terlizzo, Monica;Wotherspoon, Andrew;Brown, Gina;Swansbury, John;Lord, Christopher J;Cunningham, David;Chau, Ian;Chong, Irene Y;
Vol. 122 , pp. 12-21
415 views DOI Abstract
2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting.
Corbaux, Pauline;Maillet, Denis;Boespflug, Amélie;Locatelli-Sanchez, Myriam;Perier-Muzet, Marie;Duruisseaux, Michaël;Kiakouama-Maleka, Lize;Dalle, Stéphane;Falandry, Claire;Péron, Julien;
Vol. 121 , pp. 192-201
419 views DOI Abstract
Journament Score
40.3/100 · Below Average
Ranked #9,262 of 33,995
Journament

Overall Quality Score

40.3/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.1/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

34.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.